CAS No. 620159-04-8

Morpholine, 4-[5-(2-methoxyphenyl)-1,3-dioxo-4-pentynyl]-, ion(1-),lithium

Morpholine, 4-[5-(2-methoxyphenyl)-1,3-dioxo-4-pentynyl]-, ion(1-),lithium

Catalog No.2078071
NameMorpholine, 4-[5-(2-methoxyphenyl)-1,3-dioxo-4-pentynyl]-, ion(1-),lithium
CAS 620159-04-8
FormulaC16H16NO4・Li

2-Methoxyphenyl

Request a Quote SDS

Structure of 620159-04-8

About Morpholine, 4-[5-(2-methoxyphenyl)-1,3-dioxo-4-pentynyl]-, ion(1-),lithium

Morpholine, 4-[5-(2-methoxyphenyl)-1,3-dioxo-4-pentynyl]-, ion(1-),lithium is a chemical compound registered under CAS number 620159-04-8, with the molecular formula C16H16NO4・Li. KingPharm Group supplies Morpholine, 4-[5-(2-methoxyphenyl)-1,3-dioxo-4-pentynyl]-, ion(1-),lithium for laboratory research and bulk production; product code 2078071. Send an inquiry for purity, packaging, price and lead time.

CAS Number
620159-04-8
Molecular Formula
C16H16NO4・Li
Related Keywords
dioxo
lithium
pentynyl
morpholine
methoxyphenyl
  • 2,3-Quinoxalinedione, 6-azido-1,4-dihydro-
  • 10-{3-[(ethylamino)methyl]pyrrolidin-1-yl}-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,3,4]oxadiazino[6,5,4-ij]quinoline-6-carboxylic acid
  • 2-adamantylaspartate
  • 2-Thiabicyclo[2.2.2]oct-5-en-3-one, O-(aminocarbonyl)oxime
  • Naphtho[2,3-b]furan-2(3H)-one,5,6-bis(acetyloxy)-3-[3-(acetyloxy)propyl]-3,4-dimethyl-7-(1-methylethyl)-9-nitro-, (R)-
  • Furan, 5-methyl-3-[(4-methylphenyl)sulfonyl]-2-phenyl-
    115563-21-8
  • 2-(4-methylphenoxy)octahydro-1H-1,3,2-benzodiazaphosphole 2-oxide
  • N-tert-Butoxycarbonyl-L-ALPHA-aminosuberic acid
  • L-Proline,glycyl-L-prolylglycyl-L-alanyl-L-seryl-L-seryl-L-phenylalanyl-L-seryl-L-leucyl-L-leucyl-L-lysyl-L-glutaminyl-L-alanylglycyl-L-a-aspartyl-L-valyl-L-a-glutamyl-L-a-glutamyl-L-asparaginyl-L-prolylglycyl-
  • Benzaldehyde, 5-chloro-2-(methoxymethoxy)-
  • 2H-Pyran-4-aceticacid, 3-ethylidene-2-(b-D-glucopyranosyloxy)-3,4-dihydro-5-(methoxycarbonyl)-, 2-[2-[[[[(2S,3E,4S)-3-ethylidene-2-(b-D-glucopyranosyloxy)-3,4-dihydro-5-(methoxycarbonyl)-2H-pyran-4-yl]acetyl]oxy]methyl]-4-hydroxy-3-methylcyclopentyl]-1,3-
  • Naphtho[2,3-b]furan-2(3H)-one,8-acetyl-3-[3-(acetyloxy)propyl]-3,4-dimethyl-7-(1-methylethyl)-, (R)-
    89404-26-2
  • 6H-Benzofuro[3,2-c][1]benzopyran-6a(11aH)-ol,3,8,9-trimethoxy-10-(3-methyl-2-buten-1-yl)-, (6aS,11aS)-
  • 1H-Isoindole-1,3(2H)-dione, hexahydro-2-(2-hydroxyethyl)-
  • Palladium, bis(diphenylphosphine)-
  • 2(5H)-Furanone, 3-chloro-5-phenyl-4-[(phenylmethyl)thio]-
  • 1,2,3-Benzotriazin-4(1H)-one, 7-chloro-, 2-oxide
  • 2-[2-(Dimethylamino)ethyl]-3,4-dihydro-4-methylpyrido[3,2-f][1,4]oxazepine-5(2H)-thione/(E)-2-butenedioic acid,(1:x)
    115609-60-4
  • Benzenesulfonamide, N,4-dimethyl-N-[(4-nitrophenyl)methyl]-
  • 1,2-Pyrrolidinedicarboxylic acid, 4-(carboxymethyl)-,1-(1,1-dimethylethyl) 2-methyl ester, (2S,4R)-
  • Daechucyclopeptide 1
  • Benzenepropanamide, b-hydroxy-2-(methoxymethoxy)-N,N-dimethyl-
  • 2(5H)-Furanone,5-hydroxy-3-[2-(2,6,6-trimethyl-1-cyclohexen-1-yl)ethenyl]-, (E)-
  • 1-Propanone,3-(1-piperidinyl)-1-(4-propoxyphenyl)-, hydrochloride (1:1)
    1155-49-3
  • Cu.Ni.O.Sb
  • 1H-1,2,4-Triazole, 1-[(2,2-dimethyl-4-phenyl-1,3-dioxolan-4-yl)methyl]-
  • 1-(2-Bromophenyl)-3,5-dimethyl-1H-pyrazole
  • 4(1H)-Quinolinone, 8-methoxy-3-(1-oxobutyl)-
  • Benzenamine, 3-fluoro-N-methyl-4-[4-(trifluoromethyl)phenoxy]-
  • (13aS)-2,3,9,10-tetramethoxy-13,13-dimethyl-5,8,13,13a-tetrahydro-6H-isoquino[3,2-a]isoquinoline
    115569-75-0
  • 2(5H)-Furanone,3-chloro-4-[(4-chlorophenyl)thio]-5-(3,4-dichlorophenyl)-
  • Naphtho[2,3-b]furan-2,5,6(3H)-trione,8-(acetyloxy)-3-[3-(acetyloxy)propyl]-3,4-dimethyl-7-(1-methylethyl)-, (R)-
  • 5-ethyl-5-pentyl-1,3-diazinane-2,4,6-trione
  • Benzoic acid, 4-(8-nonenyloxy)-
  • 6H-Benzofuro[3,2-c][1]benzopyran-3,6a(11aH)-diol,10-(3-hydroxy-3-methylbutyl)-8,9-dimethoxy-, (6aS-cis)-
  • 1,2,3-Benzotriazin-4(1H)-one, 6,8-dinitro-, 2-oxide
    89403-86-1